Low Risk vs High Risk MDS - What's the Difference?

In this webinar, Dr. Marlise Luskin from Dana Farber Cancer Institute will define high-risk MDS versus low-risk MDS, impact for patients and what treatment options are available.
This webinar is brought to you by the generous support of Celgene, Takeda and Jazz Pharmaceuticals.

[@terrygermany2670]

Learning is hope is a great thing to remember. Thank you for this presentation. It has been the most helpful, recent information I have received since my husband was diagnosed in 2016. He is not eligible for transplant because he is on dialysis.

[@AAMDSIF]

Please remember we are here for you. Email [e-mail], and there are webinars for caregivers as well, like this one: www.aamds.org/webinar/emotional-and-health-impact-caregiving-2021-winter-patient-family-conference. Please let us know if you'd like to talk with someone who has experienced what you are going through as well - [e-mail]

[@amybradley5821]

Was diagnosed at 58 yrs old and am now 60. Hem/Onc is following blood counts which are dropping slowly. I have no idea what to expect in the future. I would never do a BMT but will this get me eventually? How long do I have in general? What is long term outlook? Thanks for the informative presentation.

[@katherinevaughn]

Thank you for sharing this information. I just got diagnosed. I'm 64 years old and I have stage 4 lung cancer and ms. I hope 🙏🏼 I can beat this! This is my 5th time fighting cancer. I am trying to learn as much as I can to fight. I read that the bone marrow transplant could heal MDS and stop the progression of MS. Do you agree with these findings? Thank you for your time and services. ❤️🙏🏼✝️

[@AAMDSIF]

You may also find this recording useful about transplantation for older patients: www.aamds.org/webinar/transplant-older-patients-mds